Suchergebnisse - (Person:"Belizna, Cristina")

PubPharm (77)

1

Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS) : from theory to reality

enthalten in: Clinical rheumatology | 2024

von Udry, S. | Latino, J. | Perez, S. | +7

2

Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality

enthalten in: Clinical rheumatology | 2024

von Udry, S. | Latino, J. | Perez, S. | +7

3

Correspondence and comments on American College of Rheumatology and EULAR antiphospholipid syndrome classification criteria : comment on the article by Barbhaiya et al

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Alijotas-Reig, J. | Marques-Soares, J. | Esteve-Valverde, E. | +14

4

Corrigendum to "Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group" [Placenta. 136 (2023 Apr 3) 29-34

enthalten in: Placenta | 2023

von Esteve-Valverde, E. | Alijotas-Reig, J. | Belizna, C. | +30

ErratumFor: Placenta. 2023 May;136:29-34. - PMID 37028222

5

Pregnancy outcomes in women with primary Sjögren's syndrome : an analysis of data from the multicentre, prospective, GR2 study

enthalten in: The Lancet. Rheumatology | 2023

von de Frémont, G. | Costedoat-Chalumeau, N. | Lazaro, E. | +144

6

Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group

enthalten in: Placenta | 2023

von Esteve-Valverde, E. | Alijotas-Reig, J. | Belizna, C. | +30

ErratumIn: Placenta. 2023 May 3;138:20. - PMID 37146536

7

Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2) : a multicentre, prospective, observational study

enthalten in: The Lancet. Rheumatology | 2022

von Murarasu, A. | Guettrot-Imbert, G. | Le Guern, V. | +139

8

Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients

enthalten in: International journal of molecular sciences | 2022

von Stanisavljevic, N. | Stojanovich, L. | Djokovic, A. | +8

9

Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus : the French GR2 study

enthalten in: Rheumatology (Oxford, England) | 2022

von Larosa, M. | Le Guern, V. | Guettrot-Imbert, G. | +120

10

Inclusion Body Myositis and Neoplasia : A Narrative Review

enthalten in: International journal of molecular sciences | 2022

von Damian, L. | Login, C. | Solomon, C. | +6

1
2
3
4
5
6
7
8
Nächster »
[8]